Start: October 10, 2018
End: March 2022
Primary progressive aphasia (PPA) is a neurodegenerative disease that is characterized by the gradual loss of language functioning. This study will test the effects of multiple consecutive transcranial direct current stimulation (tDCS) sessions paired with language therapy in adults with PPA. tDCS is a noninvasive therapy that delivers electrical current to the brain. Participants will initially undergo either active or sham stimulation during a 45-minute oral and written speech-language therapy session. After a two-month washout period, participants will undergo the treatment that they previously didn't receive. Researchers will investigate whether combining the two interventions will enhance word retrieval deficits in PPA and slow the loss of language functioning.
Minimum Age: 18 Years
Maximum Age: 100 Years
Contact study personnel listed either under the general study contact or the location nearest you.
Lead: Johns Hopkins University
Source: ClinicalTrials.gov ID: NCT03728582